Semaglutide Inducing Resolution of Proliferative Diabetic Retinopathy: A Case Report
2024
Semaglutide and Proliferative Diabetic Retinopathy
Sample size: 1
publication
Evidence: low
Author Information
Author(s): Daniel Cool, James Coventon, Abhishek Sharma
Primary Institution: Princess Alexandra Hospital, Brisbane, Queensland, Australia
Hypothesis
Can semaglutide induce regression of proliferative diabetic retinopathy (PDR) independent of glycaemic control?
Conclusion
This case report suggests a potential independent role for semaglutide in managing PDR.
Supporting Evidence
- Semaglutide therapy led to resolution of neovascularisation in the patient's right eye.
- The patient showed improvement in diabetic macular oedema within 6 weeks of treatment.
- Despite minimal changes in glycaemic control, the patient's eye condition improved significantly.
Takeaway
A woman with diabetic eye problems got better after taking a medicine called semaglutide, even though her blood sugar didn't change much.
Methodology
Case report.
Limitations
The findings are based on a single case and may not be generalizable.
Participant Demographics
47-year-old woman with Type 2 diabetes, obesity, hypertension, and dyslipidaemia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website